Overview

Oncology Information System Market (OIS) is estimated to value over CAGR of over 7% during the forecast period 2022 to 2028.

Oncology information system (OIS) is used to manage the data of cancer patient treatment programmes, treatments plans, treatment deliveries, treatment summaries and diagnostic results. The OIS will encircle the information exchange with other departments within the health care enterprise and it must be connected to other hospitals information system. It will assist in the evaluation and improvement of therapy from information on cancer stage and treatment. OIS accredits improved medical safety and professional effectiveness. There are various resources like paper-based (hospital registries), network etc., which will help to maintain oncology information at healthcare enterprise. 

The increasing demand for IT services due to increasing prevalence is expected to fuel the growth of oncology information systems market. It is advantageous over traditional methods of data handling & validations and it further decreased the manual effort and automated the process. Along with this, the oncology information system has huge applicability in healthcare settings for better management of cancer patients. Further, changing healthcare policies to encourage smart technologies led to robust growth of oncology information systems market. Additionally, it improves patient care and helps in better management of cancer patients. All these factors led to significant growth of burgeoning growth of oncology information systems market  

Global Oncology information system market is dominated by North America and Europe due to high penetration and well-established healthcare systems. Further, they are expected to remain dominant throughout the forecast period. The Asia Pacific is expected to create a lot of opportunities for manufacturers due to the high patient population. Latin America and Rest of World Oncology information systems market are expected to witness slow growth over the forecast period due to slow adoption.

Oncology Information Systems market is expected to witness new players during the forecast period due to the increasing importance of information systems in data management.

Market players include:

Accuray Incorporated, Bogardus Medical Systems, Inc., Cerner Corporation, CureMD Corporation, Elekta AB, Flatiron Health, Inc., Koninklijke Philips N.V., McKesson Corporation, RaySearch Laboratories AB, and Varian Medical Systems, Inc.

Oncology Information System Market Segmentation:

By Application

• Surgical Oncology
• Radiation Oncology
• Medical Oncology

By Products and Services

• Software
• Patient Information Systems
• Treatment Planning Systems
• Professional Services
• Consulting/Optimization Services
• Implementation Services
• Post-sale & Maintenance Services

By End User

• Hospitals
• Diagnostic Laboratories
• Outpatient Centres
• Clinics

By Region

• Europe
• North America  
• APAC  
• Latin America
• Middle East and Africa

Competitive Landscape:  

• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players 
• Emerging players which are growing rapidly 
• New Entrants  

FutureWise Takeaways:  

• Growth prospects  
• SWOT analysis 
• Key trends 
• Key data-points affecting market growth  

Objectives of the Study:

• To provide with an exhaustive analysis on global oncology information system market by application, products and services type, end-user and region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market  
• To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions 
• Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
           1.1. Objectives of the Study 
           1.2. Market Definition 
           1.3. Market Scope 
                   1.3.1. Years Considered for the Study
                   1.3.2. Market Covered
           1.4. Currency 
           1.5. Limitations 
           1.6. Stakeholders 
 2.  Research Methodology 
           2.1. Research Data 
                   2.1.1. Secondary Data
                           2.1.1.1. Key Data from Secondary Sources
                   2.1.2. Primary Data
                            2.1.2.1. Key Data from Primary Sources
           2.2. Market Size Estimation 
           2.3. Market Breakdown and Data Triangulation 
           2.4. Assumptions for the Study  
3. Executive Summary
           3.1. Market Outlook
           3.2. Segment Outlook
           3.3. Competitive Insights
4. Global Oncology Information System Market Variables, Trends & Scope
           4.1. Market Lineage Outlook
           4.2. Penetration and Growth Prospect Mapping
           4.3. Industry Value Chain Analysis
           4.4. Cost Analysis Breakdown
           4.5. Technology Overview
           4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Oncology Information System Market Overview
           5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                             5.1.1.1. Increasing focus of Oncology Information System Companies on Brand Protection
                             5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                             5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
                  5.1.3. Industry Challenges
                             5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Oncology Information System Market Analysis Tools
           6.1. Industry Analysis - Porter’s
                   6.1.1. Supplier Power
                   6.1.2. Buyer Power
                   6.1.3. Substitution Threat
                   6.1.4. Threat from New Entrants
                   6.1.5. Competitive Rivalry
           6.2. Pestel Analysis
                   6.2.1. Political Landscape
                   6.2.2. Environmental Landscape
                   6.2.3. Social Landscape
                   6.2.4. Technology Landscape
                   6.2.5. Legal Landscape
           6.3. Major Deals And Strategic Alliances Analysis
                   6.3.1. Joint Ventures
                   6.3.2. Mergers and Acquisitions
                   6.3.3. Licensing and Partnership
                   6.3.4. Technology Collaborations
                   6.3.5. Strategic Divestments
           6.4. Market Entry Strategies
           6.5. Case Studies
7. Global Oncology Information System Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
          7.1 Surgical Oncology
          7.2 Radiation Oncology
          7.3 Medical Oncology
8. Global Oncology Information System Market, By Products and Services Historical Analysis and Forecast 2022-2028 (USD Million)
           8.1. Software
                   8.1.1. Patient Information Systems
                   8.1.2. Treatment Planning Systems
           8.2. Professional Services
                   8.2.1. Consulting/Optimization Services
                   8.2.2. Implementation Services
                   8.2.3. Post-sale & Maintenance Services
9. Global Oncology Information System Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
           9.1. Hospitals
           9.2. Diagnostic Laboratories
           9.3. Outpatient Centres
           9.4. Clinics
10. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           10.1. Introduction
           10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     10.2.1. U.S.A
                     10.2.2. Canada
                     10.2.3. Mexico
           10.3. Market Size (USD Million) Forecast for North America 2022-2028 
11. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           11.1. Introduction
           11.2. Regional Market Trends
           11.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     11.3.1. Brazil
                     11.3.2. Venezuela
                     11.3.3. Argentina
                     11.3.4. Rest of Latin America
           11.4. Market Size (USD Million) Forecast for Latin America 2022-2028  
12. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           12.1. Introduction
           12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     12.2.1. Germany
                     12.2.2. U.K
                     12.2.3. France
                     12.2.4. Italy
                     12.2.5. Spain
                     12.2.6. Russia
                     12.2.7. Poland
                     12.2.8. Switzerland
                     12.2.9. Rest of Western Europe
           12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           13.1. Introduction
           13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     13.2.1. Japan
                     13.2.2. China
                     13.2.3. Singapore
                     13.2.4. India
                     13.2.5. Australia and New Zealand
                     13.2.6. ASEAN
                     13.2.7. South Korea
                     13.2.8. Taiwan
                     13.2.9. Rest of Asia Pacific
           13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           14.1. Introduction
           14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     14.2.1. GCC
                     14.2.2. Israel
                     14.2.3. South Africa
                     14.2.4. Rest of MEA
           14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
           15.1. Accuray Incorporated
                     15.1.1. Company Overview
                     15.1.2. Product Portfolio
                     15.1.3. SWOT Analysis
                     15.1.4. Financial Overview
                     15.1.5. Strategic Overview
           15.2. Bogardus Medical Systems, Inc.
                     15.2.1. Company Overview
                     15.2.2. Product Portfolio
                     15.2.3. SWOT Analysis
                     15.2.4. Financial Overview
                     15.2.5. Strategic Overview
           15.3. Cerner Corporation
                     15.3.1. Company Overview
                     15.3.2. Product Portfolio
                     15.3.3. SWOT Analysis
                     15.3.4. Financial Overview
                     15.3.5. Strategic Overview
           15.4. CureMD Corporation
                     15.4.1. Company Overview
                     15.4.2. Product Portfolio
                     15.4.3. SWOT Analysis
                     15.4.4. Financial Overview
                     15.4.5. Strategic Overview
           15.5  Elekta AB
                     15.5.1. Company Overview
                     15.5.2. Product Portfolio
                     15.5.3. SWOT Analysis
                     15.5.4. Financial Overview
                     15.5.5. Strategic Overview
           15.6 Flatiron Health, Inc.
                     15.6.1. Company Overview
                     15.6.2. Product Portfolio
                     15.6.3. SWOT Analysis
                     15.6.4. Financial Overview
                     15.6.5. Strategic Overview
           15.7. Koninklijke Philips N.V.
                     15.7.1. Company Overview
                     15.7.2. Product Portfolio
                     15.7.3. SWOT Analysis
                     15.7.4. Financial Overview
                     15.7.5. Strategic Overview
           15.8. McKesson Corporation
                     15.8.1. Company Overview
                     15.8.2. Product Portfolio
                     15.8.3. SWOT Analysis
                     15.8.4. Financial Overview
                     15.8.5. Strategic Overview
           15.9. RaySearch Laboratories AB
                     15.9.1. Company Overview
                     15.9.2. Product Portfolio
                     15.9.3. SWOT Analysis
                     15.9.4. Financial Overview
                     15.9.5. Strategic Overview
           15.10. Varian Medical Systems, Inc.
                     15.10.1. Company Overview
                     15.10.2. Product Portfolio
                     15.10.3. SWOT Analysis
                     15.10.4. Financial Overview
                     15.10.5. Strategic Overview
16. Pre and Post COVID-19 Impact
    16.1. Positive influence on the healthcare industry
    16.2. The financial disruption of the manufacturing sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the healthcare regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client

Tables

Figures